Variable | Haemorrhagic STEMI (n= 29) | Non-haemorrhagic STEMI (n= 21) | p Value |
Age (years) | 55±11 | 54±11 | NS |
M/F | 28/1 | 20/1 | NS |
Body surface area (m2) | 1.96±0.18 | 1.99±0.17 | NS |
Systolic blood pressure (mm Hg) | 132±33 | 125±20 | NS |
Diastolic blood pressure (mm Hg) | 84±20 | 76±15 | NS |
Heart rate (bpm) | 74±16 | 79±19 | NS |
Diabetes mellitus | 6 (21%) | 1 (5%) | NS |
Current or ex-smoker | 14 (48%) | 15 (72%) | NS |
Hypertension | 8 (28%) | 6 (29%) | NS |
Time from symptoms to reperfusion (h) | 4.2±3.3 | 3.7±2.3 | NS |
Peak creatinine kinase (IU/l) | 3235±1938 | 1683±1604 | <0.01 |
Peak troponin I (μg/l) | 111±103 | 49±59 | <0.05 |
Culprit coronary artery | |||
Left anterior descending | 19 (66%) | 7 (33%) | <0.05 |
Circumflex artery | 2 (7%) | 4 (19%) | NS |
Right coronary | 8 (28%) | 10 (48%) | NS |
TIMI flow pre-PCI | |||
Grade 0 | 27 (93%) | 16 (76%) | NS |
Grade I | 2 (7%) | 1 (5%) | NS |
Grade II | 0 | 2 (10%) | NS |
Grade III | 0 | 2 (10%) | NS |
TIMI flow post-PCI | |||
Grade II | 2 (7%) | 0 | NS |
Grade III | 27 (93%) | 21 (100%) | NS |
Medication given during admission | |||
Aspirin | 29 (100%) | 21 (100%) | NS |
Clopidogrel | 28 (97%) | 20 (95%) | NS |
Beta-blocker | 25 (86%) | 18 (86%) | NS |
Ca2+ channel blocker | 1 (3%) | 1 (5%) | NS |
ACE inhibitor | 29 (100%) | 18 (86%) | NS |
Statin | 6 (21%) | 4 (19%) | NS |
Glycoprotein IIb/IIIa antagonist | 27 (93%) | 17 (81%) | NS |
Heparin | 29 (100%) | 21 (100%) | NS |
Values given as n (%) or mean±SD.
PCI, primary coronary intervention; STEMI, ST elevation myocardial infarction; TIMI, Thrombolysis in Myocardial Infarction trial grading.